Prostate Cancer
Risk factors for febrile neutropenia in patients receiving docetaxel chemotherapy for castration-resistant prostate cancer - Abstract
August 13, 2014
Prognostic value of seminal vesicle involvement due to prostate cancer in radical prostatectomy specimens - Abstract
August 13, 2014
The oncologic role of local treatment in primary metastatic prostate cancer - Abstract
August 13, 2014
A phase II study of GW786034 (pazopanib) with or without bicalutamide in patients with castration-resistant prostate cancer - Abstract
August 13, 2014
A population study of fasting time and serum prostate-specific antigen (PSA) level - Abstract
August 12, 2014
Stress and self-efficacy predict psychological adjustment at diagnosis of prostate cancer - Abstract
August 12, 2014
Reduced rate of repeated prostate biopsies observed in ConfirmMDx clinical utility field study - Abstract
August 12, 2014
Five-year nationwide follow-up study of active surveillance for prostate cancer - Abstract
August 12, 2014
Predicting the risk of harboring high-grade disease for patients diagnosed with prostate cancer scored as Gleason ≤ 6 on biopsy cores - Abstract
August 12, 2014
Combining enzalutamide with abiraterone, prednisone, and androgen deprivation therapy in the STAMPEDE trial - Abstract
August 11, 2014